Search
forResearch 10 of 56
- Alopecia secondary to severe discoid lupus responding to anifrolumab
- Anifrolumab for systemic lupus erythematosus: A clinical study of Japanese patients in Kanazawa University Hospital
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- PT4:07 Anifrolumab as rescue therapy in life-threatening, infection-complicated SLE: a biomarker-guided case beyond trial criteria
- PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort
- PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- AB0987 ANIFROLUMAB TREATMENT IMPROVES QUALITY OF LIFE AND DECREASES SYSTEMIC CORTICOSTEROID USE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- P133 Anifrolumab treatment improves quality of life and decreases corticosteroid use in patients with SLE
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →